Drugs / Iobitridol
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 43 trials | ||||||
| Phase 4 | NCT01255722 | Nov 2010 → Sep 2012 | coronary artery disorder | Guerbet | Completed | No outcome recorded |
| Phase 4 | NCT01254552 | Aug 2010 → Sep 2011 | coronary atherosclerosis, type 2 diabetes mellitus | Guerbet | Completed | No outcome recorded |
| Phase 4 | NCT00382317 | Aug 2006 → Feb 2008 | — | Guerbet | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT01908309 Comparator | Apr 2013 → Oct 2014 | acute kidney injury | Azienda Sanitaria Locale 9, Grosseto | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | iobitridol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01255722 ↗ |
| Modality | Diagnostic / imaging agent | “Patients suspected of coronary artery disease were submitted to coronary CT angiography using either iobitridol or contrast agents with higher iodine concentrations (iopromide...” NCT01255722 ↗ |
| Route | Intravenous | “Patients were IV injected with a single dose of iobitridol before a coronary CT angiography” NCT01255722 ↗ |